World J Mens Health.
2024 Oct;42(4):762-771. 10.5534/wjmh.230164.
Patient Satisfaction with Oral Testosterone Undecanoate in Men Who Received Prior Testosterone Therapy: An Open-Label, SingleCenter Clinical Trial
- Affiliations
-
- 1Desai Sethi Urology Institute, University of Miami Miller School of Medicine, FL, USA
- 2Herbert Wertheim College of Medicine, Florida International University, FL, USA
- 3Biostatistics and Bioinformatics Shared Resource, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, FL, USA
- 4Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA
- KMID: 2559715
- DOI: http://doi.org/10.5534/wjmh.230164
Abstract
- Purpose
To evaluate patient satisfaction and symptom control in hypogonadal men transitioning from other testosterone therapies to oral testosterone undecanoate (TU).
Materials and Methods
In this open-label clinical trial, men aged 18 to 75 years with hypogonadism were switched to oral TU after a sufficient washout of previous testosterone therapies. Treatment satisfaction and symptom control were primarily measured using the 9-item Treatment Satisfaction Questionnaire for Medication (TSQM-9) and quantitative androgen deficiency in aging males (qADAM) questionnaires, respectively. Secondary outcomes included changes in serum testosterone (T), estradiol (E2), hematocrit (HCT), and prostate-specific antigen (PSA) levels.
Results
Forty-one men participated, with significant improvements in all TSQM-9 scores observed over 6 months. Symptom control as measured by qADAM remained consistent. There was a significant increase in serum T and E2 levels, but HCT and PSA levels remained stable.
Conclusions
Switching to oral TU from other testosterone therapies is associated with increased patient satisfaction and stable hypogonadal symptom control.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Oral Testosterone Undecanoate(Andriol(R)) for Increasing Serum Testosterone Level in Late Onset Hypogonadism Patients
- Oral Testosterone Undecanoate Versus Transdermal Testosterone Gel for the Treatment of Testosterone Deficiency Syndrome: A Retrospective Comparative Study
- Comparison of Intratesticular Testosterone between Men Receiving Nasal, Intramuscular, and Subcutaneous Pellet Testosterone Therapy: Evaluation of Data from Two Single-Center Randomized Clinical Trials
- Polycythemia as a Complication of Long-acting Injectable Testosterone Undecanoate
- Testosterone therapy in men with testosterone deficiency: Are we beyond the point of no return?
